Zydus receives USFDA approval for Efinaconazole Topical Solution

20 Jul 2022 , 01:32 AM

Zydus Lifesciences subsidiary Zydus Worldwide DMCC has received final approval from the United States Food and Drug Administration USFDA to market Efinaconazole Topical Solution 10Percentage US RLD Jublia Efinaconazole is an azole antifungal used for the topical treatment of Onychomycosis of the toenails due to Trichophyton rubrum and Trichophyton mentagrophytes The drug will be manufactured at the groups topical manufacturing facility at Ahmedabad India Jublia Efinaconazole topical solution 10Percentage had annual sales of $292 million in the United States according to IQVIA data IQVIA MAT May 2022